Infusion Pump Market Size, Share, and Trends

Infusion Pump Market (By Product: Accessories and Consumables, Devices; By application: Chemotherapy/Oncology, Diabetes Management, Gastroenterology, Pain Management/ Analgesia, Pediatrics/ Neonatology, Hematology, Other Applications; By End User: Hospitals, Home Care Settings, Ambulatory Care Settings, Academic and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

  • Last Updated : September 2023
  • Report Code : 1921
  • Category : Healthcare

Infusion Pump Market Size and Companies

The global infusion pump market size was estimated at USD 14 billion in 2022 and is expected to hit around USD 28.72 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 7.50% from 2023 and 2032.

Infusion Pump Market Size 2022 To 2030

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

 

Key Takeaways:

  • The North America infusion pump market was valued at USD 4.8 billion in 2022.
  • The hospitals segment has registered highest market share of over 49% in 2022.
  • North America region has reached market share of over 38% in 2022.

Pumps of different kinds convey supplements or prescription to patients, for example, insulin or different chemicals, anti-microbials, chemotherapy medications, and pain killers. These gadgets have various benefits over manual liquid organization, including the capacity to convey liquids in tiny volumes at unequivocally modified rates or at computerized stretches. Undiscovered developing business sectors like India and China, as well as the developing reception of specialty imbuement pumps, give critical learning experiences to implantation pump market players. Nonetheless, the rising rate of medicine blunders and the absence of remote availability in many emergency clinics will present huge difficulties to the market's development during the figure time frame.

Growth factors

Demand for Pumps in Coronavirus Infection Disease Management to Improve Business Prospects Because of the effect of the COVID-19 pandemic and the vulnerability encompassing its term, the business has seen a huge expansion in its development rate. This is fundamentally because of an expansion in COVID-19 testing in 2020. In any case, there was a lessening underway because of the COVID-19 pandemic because of an absence of laborers and production network disturbances. During the COVID-19 pandemic, for instance, Baxter International saw critical and capriciousness in the interest for specific medical care items. In any case, new item dispatches have supported income development in 2020. For instance, in Jan 2020, Medtronic Ireland sent off Efficio, which is connected to the SynchroMed II intrathecal drug conveyance framework.

The rising commonness of constant illnesses, joined with the increasing expense of medical clinic based implantation treatments, has powered expanded innovative work endeavors to make locally situated mixture items. For instance, the developing patient populace in diabetes, disease, and neurological issues has brought about an expansion popular for long haul care, ideally at home. Moreover, the developing geriatric populace needing long haul care treatments is driving the advancement of new items focused on locally established mixture treatments. The market's top players are zeroing in on specialty medication site of care the board. Ivenix, Inc. fostered the Epic savvy implantation pump in August 2020 to assist patients with staying away from imbuement related wounds.

Type Insights

As a result of the increasing number of diabetic patients, the insulin pump fragment is supposed to rule the market. Volumetric pumps, needle pumps, enteral taking care of pumps, insulin pumps, elastomeric pumps, implantable pumps, and patient control absense of pain pumps are the market fragments. In the worldwide market, the insulin pump section overwhelmed. The section is supposed to keep up with its predominance by extending at a very quick rate during the estimate time frame. This is because of an expansion in the quantity of type 1 diabetic patients around the world, as well as the presentation of promising advancements in the insulin pump field. Developing agony the board applications for PCA pumps are supposed to drive worldwide item interest before long. This is because of an expansion in the adoption of mechanically progressed volumetric implantation pumps with capacities, for example, electronic wellbeing record joining, worked in security frameworks, and medication library, which is a rundown of medications put away in the brilliant pump's memory and fills in as a vital device to forestall medicine blunders.

Besides, as non-industrial nations' financial possibilities improve, more individuals are supposed to have the option to pick the utilization of volumetric pumps in home medical services, which is the essential driving element of the volumetric imbuement pump section. Based on application, the oncology section drove the market in 2020 and is supposed to keep up with its lead all through the estimate period. This is because of the expanded predominance of malignant growth, as these pumps are broadly used to direct medications during disease treatment.

Application Insights

Diabetes application segment to hold huge share due to increasing diabetes prevalence throughout the world. Diabetes, oncology, torment the board, and other market portions are instances of utilization. Diabetes had the biggest portion of the infusion pump market in 2022. The section is supposed to develop at the quickest compound annual growth rate during the conjecture time frame.

Due to the rising predominance of different diseases and the rising number of new item dispatches around here, the oncology section is supposed to get forward momentum. This pump can likewise be utilized in gastroenterology, hematology, pediatrics, sedation, blood bonding, and different fields.

End User Insights

Hospitals are supposed to overwhelm the worldwide market. As a result of rising emergency clinic confirmations around the world. The market is separated into emergency clinics, wandering consideration settings, specialty facilities, and home consideration settings in view of the end clients.

The clinics section represented the biggest portion of the market in 2022 because of emergency clinics' high buying force of the most costly mixture gadgets, huge patient pool visiting these offices, and status of prepared staff to work the pump. In any case, the home consideration settings fragment is supposed to develop at the quickest compound annual growth rate during the conjecture time frame because of expanded reception of mobile pumps and an inclination for site of care the board to diminish cost trouble. Besides, rising government drives to decrease in general medical care costs related with delayed hospitalization are probably going to help the rising interest for homecare imbuement frameworks. Implantation pumps and ventilators are basic gadgets since they are utilized in ICUs, CCUs, and crisis offices. In COVID wards, IV imbuement is a typical need. Infusion pumps are utilized in clinics and other trauma centers to control and convey medicine portions. Since they can be modified to do as such without steady oversight, they permit specialists and attendants to treat patients while presenting them to minimal measure of disease.

Accordingly, interest for infusion pumps expanded essentially in 2022. This made the stock and appropriation of infusion pumps very troublesome. The inclination for homecare settings has developed fundamentally as long haul care spending has expanded. Walking imbuement pumps in homecare settings are turning out to be better known as hospitalization costs rise and the commonness of persistent illnesses rises. The expanded reception of walking implantation pumps and the expanded need to lessen medical clinic stays are basic variables driving the flood popular for wandering infusion pumps in homecare settings. The worldwide intravenous infusion pump market is separated into four classifications: type, application, end client, and district.

Geography Insights

The North America region accounted largest market share in 2022. The district's market is recognized by higher diabetes conclusion and treatment rates, as well as boundless utilization of mobile pumps and ideal repayment arrangements. Clinical gadget mechanical headways in North America are supporting the district's development.

Europe had the second biggest piece of the pie. An expansion in the commonness of persistent sicknesses around here, as well as huge consumption in the medical services area by the European Commission, are supposed to drive interest for these pumps in Europe somewhere in the range of 2023 and 2032.

The market in arising locales like Latin America, Asia Pacific, the Middle East and Africa is supposed to develop at a quicker rate during the conjecture time frame. Ascend in the predominance of persistent illnesses like diabetes and disease, developing medical care framework, developing GDP, extra cash, and expanding mindfulness about the accessibility of cutting-edge treatments in the Asia Pacific district are a portion of the variables expected to drive market development around here before long. The Asia Pacific market is supposed to develop at a 8.8% compound annual growth rate during the gauge time frame.

The market in Latin America, the Middle East, and Africa is still in its earliest stages. Notwithstanding, the rising focal point of driving players on growing their presence in these locales will support the market in these areas. China, Japan, and India are instances of arising economies with advanced medical care foundation and offices. Characteristics, for example, high illness trouble, huge government changes, reception of new innovation, and low treatment costs are preparing for market development.

North America overwhelmed the market in 2022, and this pattern is supposed to go on all through the estimate period. The rising commonness of persistent illnesses, the rising number of surgeries performed, advanced and extending R&D, and the rising reception of cutting-edge innovation in implantation pumps generally added to the development of the market around here.

Key market developments

  • Mindray has presented the BeneFusion n Series, another age imbuement framework. It gives profound experiences into patient security, interoperability and information the board, and functional effortlessness, all of which add to the foundation of new guidelines in mixture treatment.
  • Teknor Apex Co., a plastics intensifying organization, presented new, profoundly weatherable mixtures for the external layers of dim shaded wood plastic composite (WPC) decking in February 2021. WPC decking is produced using a blend of wood flour and polyolefin plastics and is turning out to be progressively well known as an option in contrast to customary treated wood. The new mixtures might give a huge benefit to WPC over wood by giving a prevalent appearance, lower upkeep prerequisites, and a more extended life expectancy.
  • AZEk, a composite board producer, declared in March 2021 the development of another plant in Boise, Idaho, to extend its creation of composite wood utilizing reused PE. As per the Chicago-based producer, retrofitting and development of the office will start before the current year's over, with the plant expected to be functional in 2022. AZEK plans to produce its TimberTech image blunder, produced using recuperated PE and wood, at the Boise production line, which is essential for a US$180 million limit development program.

Report Scope of the Infusion Pump Market

Report Coverage Details
Market Size in 2023 USD 14.98 Billion
Market Size by 2032

USD 28.72 Billion

Growth Rate from 2023 to 2032 CAGR of 7.50%
Base Year 2022
Forecast Period 2023 to 2032
Market Segmentation

By Product

  • Accessories and Consumables
    • Dedicated Accessories and Consumables
      • Volumetric Infusion Pumps
      • Insulin Pumps
      • Enteral Infusion Pumps
      • Syringe Infusion Pumps
      • Ambulatory Infusion Pumps
      • PCA Pumps
      • Implantable Infusion Pumps
    • Non- Dedicated Accessories and Consumables
      • Infusion Catheters
      • IV/administration Sets
      • Needleless Connectors
      • Cannulas
      • Tubing & Extension Sets
      • Valves
      • Other Non- Dedicated Accessories and Consumables
  • Devices
    • By Product
      • Volumetric Infusion Pumps
      • Insulin Pumps
      • Enteral Infusion Pumps
      • Syringe Infusion Pumps
      • Ambulatory Infusion Pumps
      • PCA Pumps
      • Implantable Infusion Pumps
    • By Technology
      • Traditional Infusion Pumps
      • Specialty Infusion Pumps
    • By Type
      • Stationary Infusion Pumps
      • Portable Infusion Pumps

By Application

  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Pain Management/ Analgesia
  • Pediatrics/ Neonatology
  • Hematology
  • Other Applications         

By End User

  • Hospitals
  • Home Care Settings
  • Ambulatory Care Settings
  • Academic and Research Institutes

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Companies Mentioned
  • Tandem Diabetes Care, Inc.
  • Smith Medical                         
  • Terumo Corporation
  • Becton, Dickinson and Company
  • Fresenius SE & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • B. Braun Holding GmbH & Co. KG
  • Baxter International, Inc.
  • Medtronic
  • ICU Medical, Inc.

 

Frequently Asked Questions

The global infusion pump market size was accounted at USD 14 billion in 2022 and it is expected to reach around USD 28.72 billion by 2032.

The global infusion pump market is poised to grow at a CAGR of 7.50% from 2023 to 2032.

The major players operating in the infusion pump market are Tandem Diabetes Care, Inc., Smith Medical, Terumo Corporation, Becton, Dickinson and Company, Fresenius SE & Co. KGaA, F. Hoffmann-La Roche Ltd., B. Braun Holding GmbH & Co. KG, Baxter International, Inc., Medtronic, ICU Medical, Inc.

The rising awareness of ongoing infections is supposed to drive market development

North America region will lead the global infusion pump market during the forecast period 2023 to 2032.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infusion Pump Market 

5.1. COVID-19 Landscape: Infusion Pump Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infusion Pump Market, By Product

8.1. Infusion Pump Market, by Product, 2023-2032

8.1.1 Accessories and Consumables

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Devices

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Infusion Pump Market, By Application

9.1. Infusion Pump Market, by Application, 2023-2032

9.1.1. Chemotherapy/Oncology

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Diabetes Management

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Gastroenterology

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Pain Management/ Analgesia

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Pediatrics/ Neonatology

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Hematology

9.1.6.1. Market Revenue and Forecast (2020-2032)

9.1.7. Other Applications 

9.1.7.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Infusion Pump Market, By End User 

10.1. Infusion Pump Market, by End User, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Home Care Settings

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Ambulatory Care Settings

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Academic and Research Institutes

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Infusion Pump Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.3. Market Revenue and Forecast, by End User (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End User (2020-2032)

Chapter 12. Company Profiles

12.1. Tandem Diabetes Care, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Smith Medical

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Terumo Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Becton, Dickinson and Company

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Fresenius SE & Co. KGaA

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. F. Hoffmann-La Roche Ltd.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. B. Braun Holding GmbH & Co. KG

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Baxter International, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Medtronic

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. ICU Medical, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client